跳至主要内容
临床试验/NCT05115825
NCT05115825已完成不适用

Survivors of Head and Neck Cancer: Optimizing Pain Management

OHSU Knight Cancer Institute4 个研究点 分布在 1 个国家目标入组 33 人开始时间: 2019年4月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
33
试验地点
4
主要终点
Depression

研究概览

简要总结

This clinical trial improves an existing pain management program and tests its effect on head and neck cancer survivors. This trial aims to find a better program to improve pain-related physical functioning, mood, and quality of life in a sample of individuals who have undergone treatment for head and neck cancer.

详细描述

PRIMARY OBJECTIVES:

I. Adapt an existing telehealth pain management intervention to target improvement of pain-related physical functioning, mood, substance use, and quality of life in a local sample of veteran head and neck cancer (HNC) survivors.

II. Conduct a pilot of the adapted intervention to examine the feasibility (accrual, adherence, attrition) and acceptability (participant satisfaction) that will form the basis of a well-powered, randomized clinical trial submitted for funding to the National Institutes of Health (NIH), American Cancer Society (ACS), or Veterans Affairs (VA).

OUTLINE:

Patients attend 5 sessions of Mobile Pain Coping Skills Training for 45 minutes each over 8 weeks.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Clinically confirmed diagnosis of HNC for which the participants have completed curative cancer treatment at the VA hospital or Oregon Health & Science University (OHSU) within the 3-12 months following treatment
  • Self-reported current pain of 4 or higher, using the 0-10 Numeric Pain Rating (NRS) (0="no pain" to 10="the worst pain imaginable")
  • Self-report of pain 4 or higher on two occasions, more than three weeks apart, since the completion of curative treatment

排除标准

  • Enrolled in hospice
  • Have substantial hearing or visual difficulties that would impair ability to participate
  • Have inadequate cognitive functioning as indicated by medical record review and/or interactions with clinical staff. If needed the investigators can follow up with the St. Louis University Mental State Examination (score of < 22/30) (SLUMS); or
  • Have untreated severe psychiatric illness that would impact the ability to consent and participate in the intervention
  • Had only surgical treatment for their HNC

结局指标

主要结局

Depression

时间窗: Up to 2 months

Will be assessed by the Patient Health Questionnaire. Scores of 5, 10, 15, and 20 represent point scale for mild, moderate, moderately severe and severe depression, respectively.

Pain-interference

时间窗: Up to 2 months

Will be assessed by Brief Pain Inventory. Will be assessed as 1-4=mild pain; 5-6 moderate pain; 7-10 severe pain.

Pain coping self-efficacy

时间窗: Up to 2 months

Will be assessed by the Chronic Pain Self-Efficacy Scale.

次要结局

  • Head and neck cancer related quality of life(Up to 2 months)
  • Substance use(Up to 2 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Shannon Madore, Ph.D.

Principal Investigator

OHSU Knight Cancer Institute

研究点 (4)

Loading locations...

相似试验